Cathie's Ark Logo
Exact Sciences Corp. Logo

ARKK Holdings of Exact Sciences Corp. (EXAS) - Updated Daily

Liquid BiopsyGenomicsGenetic Testing
Date
Direction
Shares
Fund Weight
Fund
March 28, 2023
SELL21.585k0.0198%ARKK
March 27, 2023
SELL41.985k0.0393%ARKK
March 23, 2023
SELL13.693k0.0123%ARKK
March 22, 2023
SELL1.805k0.0016%ARKK
March 21, 2023
SELL45.172k0.0399%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
6.39%$12.02b
🏋🏿‍♂️Weight Rank In ARKK🌏Country
5🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
3$106.19
🎫ARK Ownership Percent
3.96%
Description
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer.
Website
www.exactsciences.com

Other ETFs That Hold EXAS

Ticker
NameWeight
ARKGARK Genomic Revolution ETF11.77%
ARKKARK Innovation ETF6.43%
XBISPDR® S&P Biotech ETF1.49%
AGNGGlobal X Aging Population ETF0.85%